RankAlpha logo
Back to Rankings

DCBO

DoceboF
Nasdaq / Software & Services
Last Price
Quote time unavailable
View Chart
Documents
62
Stored
Transcripts
1
Recent loaded
Latest report
2026-09-11
Investor release

Document history

Earnings documents stored for DCBO.

12 shown
Investor releaseQuarter not tagged2026-09-11

Docebo Inc. Announces Final Results of its Substantial Issuer Bid

Business Wire
TORONTO, September 11, 2026--(BUSINESS WIRE)--Docebo Inc. (NASDAQ: DCBO; TSX: DCBO) ("Docebo" or the "Company"), the Enterprise Platform for the AI-era workforce, unifying skills intelligence, learning, and knowledge in one closed loop, announced today that it will take up and purchase for cancellation 99,332 of its common shares (the "Common Shares") at a purchase price of US$25.00 per Common Share under the Company’s substantial issuer bid (the "Offer"), for aggregate consideration of US$2,483,300. Common Shares purchased under the Offer represent approximately 0.4% of the issued and outstanding Common Shares on a non-diluted basis as at July 20, 2026, when the terms of the Offer were announced. After giving effect to the Offer and the exercise of Company stock options between the launch and completion of the Offer, 24,947,594 Common Shares will be issued and outstanding. A total of 99,332 Common Shares were properly tendered to the Offer and not withdrawn. Intercap Inc. ("Intercap"), tendered 13,351 Common Shares pursuant to the Offer, representing less than 0.1% of its holdings. Intercap continues to beneficially own 15,900,000 Common Shares, representing approximately 63.7% of the issued and outstanding Common Shares. The marginal decrease in Intercap’s ownership percentage following the Offer reflects dilution from the option exercises described above, and not an intended reduction by Intercap. No other directors or officers tendered Common Shares pursuant to the Offer. Payment for the purchased Common Shares will be effected by TSX Trust Company in accordance with the Offer and applicable law. The full details of the Offer are described in the offer to purchase and issuer bid circular dated July 20, 2026, as varied by the notice of variation and extension dated August 21, 2026, as well as the related letter of transmittal and notice of guaranteed delivery, copies of which were filed and are available on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. This news release is for informational purposes only and does not constitute an offer to buy or the solicitation of an offer to sell Common Shares. About Docebo Docebo is redefining the way enterprises leverage technology to create and manage content, deliver training, and measure the business impact of their learning programs. With Docebo’s end-to-end learning platform, organizations worldwide ar…Read full document

TORONTO, September 11, 2026--(BUSINESS WIRE)--Docebo Inc. (NASDAQ: DCBO; TSX: DCBO) ("Docebo" or the "Company"), the Enterprise Platform for the AI-era workforce, unifying skills intelligence, learning, and knowledge in one closed loop, announced today that it will take up and purchase for cancellation 99,332 of its common shares (the "Common Shares") at a purchase price of US$25.00 per Common Share under the Company’s substantial issuer bid (the "Offer"), for aggregate consideration of US$2,483,300. Common Shares purchased under the Offer represent approximately 0.4% of the issued and outstanding Common Shares on a non-diluted basis as at July 20, 2026, when the terms of the Offer were announced. After giving effect to the Offer and the exercise of Company stock options between the launch and completion of the Offer, 24,947,594 Common Shares will be issued and outstanding. A total of 99,332 Common Shares were properly tendered to the Offer and not withdrawn. Intercap Inc. ("Intercap"), tendered 13,351 Common Shares pursuant to the Offer, representing less than 0.1% of its holdings. Intercap continues to beneficially own 15,900,000 Common Shares, representing approximately 63.7% of the issued and outstanding Common Shares. The marginal decrease in Intercap’s ownership percentage following the Offer reflects dilution from the option exercises described above, and not an intended reduction by Intercap. No other directors or officers tendered Common Shares pursuant to the Offer. Payment for the purchased Common Shares will be effected by TSX Trust Company in accordance with the Offer and applicable law. The full details of the Offer are described in the offer to purchase and issuer bid circular dated July 20, 2026, as varied by the notice of variation and extension dated August 21, 2026, as well as the related letter of transmittal and notice of guaranteed delivery, copies of which were filed and are available on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. This news release is for informational purposes only and does not constitute an offer to buy or the solicitation of an offer to sell Common Shares. About Docebo Docebo is redefining the way enterprises leverage technology to create and manage content, deliver training, and measure the business impact of their learning programs. With Docebo’s end-to-end learning platform, organizations worldwide are equipped to deliver scaled, personalized learning across all their audiences and use cases, driving growth and powering their business. View source version on businesswire.com: https://www.businesswire.com/news/home/20260911705959/en/ Contacts For further information, please contact: Mike McCarthyVice President – Investor Relations(214) [email protected]

Investor releaseQuarter not tagged2026-09-09

Docebo Inc. Announces Preliminary Results of its Substantial Issuer Bid

Business Wire
TORONTO, September 09, 2026--(BUSINESS WIRE)--Docebo Inc. (NASDAQ: DCBO; TSX: DCBO) ("Docebo" or the "Company"), the Enterprise Platform for the AI-era workforce, unifying skills intelligence, learning, and knowledge in one closed loop, announced today the preliminary results of its substantial issuer bid (the "Offer") to repurchase for cancellation up to US$70,000,000 of its outstanding common shares (the "Common Shares") at a price of US$25.00 per Common Share. The Offer expired at 5:00 p.m. (Eastern Time) on September 8, 2026. All of the terms and conditions of the Offer have been complied with or waived and, based on a preliminary count by TSX Trust Company (the "Depositary"), a total of 99,332 Common Shares were properly tendered to the Offer. Accordingly, the Company expects to take up and purchase for cancellation all of such Common Shares at a purchase price of US$25.00 per Common Share, for aggregate consideration of US$2,483,300. The aggregate purchase price for the Common Shares taken up under the Offer will be funded entirely from the Company's cash on hand, with no incremental borrowings under its credit facility. The Common Shares expected to be purchased under the Offer represent approximately 0.4% of the issued and outstanding Common Shares on a non-diluted basis as of July 20, 2026, the date the terms of the Offer were publicly announced. After giving effect to the Offer, approximately 24,947,594 Common Shares are expected to be issued and outstanding. Intercap Inc. ("Intercap"), which beneficially owned 15,913,351 Common Shares prior to the Offer, representing approximately 63.9% of the Company’s issued and outstanding Common Shares, is expected to have 13,351 Common Shares acquired under the Offer. Accordingly, following the Offer, Intercap is expected to beneficially own 15,900,000 Common Shares, representing approximately 63.7% of the Company’s issued and outstanding Common Shares. No other directors or officers tendered Common Shares pursuant to the Offer. The number of Common Shares to be purchased under the Offer is preliminary, subject to verification by the Depositary and assumes that all Common Shares tendered through notices of guaranteed delivery will be delivered within the one trading day settlement period. The "specified amount" for purposes of subsection 191(4) of the Income Tax Act (Canada) is C$32.44, being the closing trad…Read full document

TORONTO, September 09, 2026--(BUSINESS WIRE)--Docebo Inc. (NASDAQ: DCBO; TSX: DCBO) ("Docebo" or the "Company"), the Enterprise Platform for the AI-era workforce, unifying skills intelligence, learning, and knowledge in one closed loop, announced today the preliminary results of its substantial issuer bid (the "Offer") to repurchase for cancellation up to US$70,000,000 of its outstanding common shares (the "Common Shares") at a price of US$25.00 per Common Share. The Offer expired at 5:00 p.m. (Eastern Time) on September 8, 2026. All of the terms and conditions of the Offer have been complied with or waived and, based on a preliminary count by TSX Trust Company (the "Depositary"), a total of 99,332 Common Shares were properly tendered to the Offer. Accordingly, the Company expects to take up and purchase for cancellation all of such Common Shares at a purchase price of US$25.00 per Common Share, for aggregate consideration of US$2,483,300. The aggregate purchase price for the Common Shares taken up under the Offer will be funded entirely from the Company's cash on hand, with no incremental borrowings under its credit facility. The Common Shares expected to be purchased under the Offer represent approximately 0.4% of the issued and outstanding Common Shares on a non-diluted basis as of July 20, 2026, the date the terms of the Offer were publicly announced. After giving effect to the Offer, approximately 24,947,594 Common Shares are expected to be issued and outstanding. Intercap Inc. ("Intercap"), which beneficially owned 15,913,351 Common Shares prior to the Offer, representing approximately 63.9% of the Company’s issued and outstanding Common Shares, is expected to have 13,351 Common Shares acquired under the Offer. Accordingly, following the Offer, Intercap is expected to beneficially own 15,900,000 Common Shares, representing approximately 63.7% of the Company’s issued and outstanding Common Shares. No other directors or officers tendered Common Shares pursuant to the Offer. The number of Common Shares to be purchased under the Offer is preliminary, subject to verification by the Depositary and assumes that all Common Shares tendered through notices of guaranteed delivery will be delivered within the one trading day settlement period. The "specified amount" for purposes of subsection 191(4) of the Income Tax Act (Canada) is C$32.44, being the closing trading price for a Common Share on the TSX on September 8, 2026. Shareholders should consult with their own tax advisors with respect to the income tax consequences of the disposition of their Common Shares under the Offer. The full details of the Offer are described in the offer to purchase and issuer bid circular dated July 20, 2026, as varied by the notice of variation and extension dated August 21, 2026, as well as the related letter of transmittal and notice of guaranteed delivery, copies of which were filed and are available on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Forward-Looking Information This news release may contain "forward-looking information" and "forward-looking statements" (collectively, "forward-looking information") within the meaning of applicable securities laws, including, without limitation, purchases of Common Shares tendered under the Offer and Intercap’s expected ownership following the Offer. This forward-looking information is based on our opinions, estimates and assumptions and there is no assurance that any Common Shares will be purchased under the Offer. Although the Company considers such opinions, estimates and assumptions to be appropriate and reasonable as of the date of this press release, they are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including those factors discussed in greater detail under the "Risk Factors" section in our Annual Information Form, available free of charge under the Company’s profile on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov, and should be considered carefully by prospective Investors. If any of these risks or uncertainties materialize, or if the opinions, estimates or assumptions underlying the forward-looking information prove incorrect, actual results or future events might vary materially from those anticipated in the forward-looking information. Although we have attempted to identify important risk factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other risk factors not presently known to us or that we presently believe are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking information. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. No forward-looking statement is a guarantee of future results. Accordingly, you should not place undue reliance on forward-looking information, which speaks only as of the date made. The forward-looking information contained in this press release represents our expectations as of the date specified herein and are subject to change after such date. However, we disclaim any intention or obligation or undertaking to update or revise any forward- looking information whether as a result of new information, future events or otherwise, except as required under applicable securities laws. All of the forward-looking information contained in this press release is expressly qualified by the foregoing cautionary statements. About Docebo Docebo is redefining the way enterprises leverage technology to create and manage content, deliver training, and measure the business impact of their learning programs. With Docebo’s end-to-end learning platform, organizations worldwide are equipped to deliver scaled, personalized learning across all their audiences and use cases, driving growth and powering their business. View source version on businesswire.com: https://www.businesswire.com/news/home/20260909391158/en/ Contacts For further information, please contact: Mike McCarthyVice President – Investor Relations(214) [email protected]

Investor releaseQuarter not tagged2026-08-07

Docebo Inc (DCBO) (Q2 2026) Earnings Call Highlights: ARR Re-acceleration and Strategic ...

GuruFocus.com
This article first appeared on GuruFocus. Release Date: August 07, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Docebo Inc (NASDAQ:DCBO) reported a second consecutive quarter of ARR re-acceleration, driven by broad-based strength across net new, expansion, and international segments. The company is seeing strong enterprise pipeline growth, with roughly 80% of enterprise deals involving partners, including key relationships with Deloitte and NIIT. The integration of 365 Talents is ahead of schedule, contributing to significant wins like the world's largest telecom and automotive safety suppliers, and expanding the company's competitive positioning. Docebo Inc (NASDAQ:DCBO) is strategically entering the healthcare vertical, a $3 billion TAM, leveraging its existing $10 million ARR base and expecting to improve win rates within months, not years. The upcoming launch of Agent Hub and Enterprise Knowledge in the fall is expected to drive new monetization opportunities and enhance the company's AI capabilities. Management raised full-year revenue guidance by $3.5 million, reflecting increased confidence in enterprise segment performance and a strong FedRAMP pipeline for Q3. Docebo Inc (NASDAQ:DCBO) is investing in a new forward-deployed engineer (FDE) model, which will initially add R&D costs before any revenue contribution, potentially pressuring near-term margins. The company's capital allocation is currently focused on share buybacks due to perceived undervaluation, but it carries $90 million in debt, and the upcoming SIB could increase net debt to $150 million. Management remains cautious about providing detailed monetization plans for the FDE model and Agent Hub, indicating uncertainty about future revenue streams. The healthcare vertical expansion is still in early stages, requiring significant investment in team and product development, with no immediate financial returns expected. While sales cycles are not elongating, the company acknowledges that the re-acceleration is partly due to lapping easier comparisons from the AWS and Dayforce headwinds, which may not be sustainable. The company's EBITDA guidance remains unchanged despite higher revenue, as investments in healthcare and R&D are expected to offset any margin improvements. Warning! GuruFocus has detected 3 Warning Sign with DCBO. Is DCBO…Read full document

This article first appeared on GuruFocus. Release Date: August 07, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Docebo Inc (NASDAQ:DCBO) reported a second consecutive quarter of ARR re-acceleration, driven by broad-based strength across net new, expansion, and international segments. The company is seeing strong enterprise pipeline growth, with roughly 80% of enterprise deals involving partners, including key relationships with Deloitte and NIIT. The integration of 365 Talents is ahead of schedule, contributing to significant wins like the world's largest telecom and automotive safety suppliers, and expanding the company's competitive positioning. Docebo Inc (NASDAQ:DCBO) is strategically entering the healthcare vertical, a $3 billion TAM, leveraging its existing $10 million ARR base and expecting to improve win rates within months, not years. The upcoming launch of Agent Hub and Enterprise Knowledge in the fall is expected to drive new monetization opportunities and enhance the company's AI capabilities. Management raised full-year revenue guidance by $3.5 million, reflecting increased confidence in enterprise segment performance and a strong FedRAMP pipeline for Q3. Docebo Inc (NASDAQ:DCBO) is investing in a new forward-deployed engineer (FDE) model, which will initially add R&D costs before any revenue contribution, potentially pressuring near-term margins. The company's capital allocation is currently focused on share buybacks due to perceived undervaluation, but it carries $90 million in debt, and the upcoming SIB could increase net debt to $150 million. Management remains cautious about providing detailed monetization plans for the FDE model and Agent Hub, indicating uncertainty about future revenue streams. The healthcare vertical expansion is still in early stages, requiring significant investment in team and product development, with no immediate financial returns expected. While sales cycles are not elongating, the company acknowledges that the re-acceleration is partly due to lapping easier comparisons from the AWS and Dayforce headwinds, which may not be sustainable. The company's EBITDA guidance remains unchanged despite higher revenue, as investments in healthcare and R&D are expected to offset any margin improvements. Warning! GuruFocus has detected 3 Warning Sign with DCBO. Is DCBO fairly valued? Test your thesis with our free DCF calculator. Q: How will the new forward-deployed engineer (FDE) model work alongside existing professional services, and what is the anticipated impact on revenue and margins? A: CEO Alessio Artuffo explained that Docebo is starting with a foundational FDE team to build a playbook before scaling. The FDEs will create custom agent workloads on top of the upcoming Agent Hub and Enterprise Knowledge releases (planned for early fall), solving specific vertical use cases in QSR, healthcare, and financial services. CFO Brandon Farma added that initially, FDE costs will be classified as R&D, but as the model scales and monetizes through usage credits or fixed pricing, it will shift to COGS, impacting gross margins. Q: What is driving the confidence in the second-half acceleration of ARR, and how does the FedRAMP government opportunity factor into Q3 seasonality? A: CEO Alessio Artuffo highlighted three vectors driving re-acceleration: overall execution, product innovation (including the 365 and Zive acquisitions), and a robust partner motion, with roughly 80% of enterprise pipeline involving partners like Deloitte and NIIT. He expressed high confidence based on strong pipeline growth, particularly in deals over $500K. Regarding government, he noted Q3 is a heavy federal quarter, but declined to provide specific guidance, emphasizing broad strength across state, local, and federal segments. Q: Can you elaborate on the decision to move into the healthcare vertical, the timeline for returns, and the gap Docebo can fill? A: CEO Alessio Artuffo stated healthcare represents a roughly $3 billion TAM within the $30 billion corporate learning market. Docebo already has about $10 million of ARR from healthcare customers. He drew parallels to the government investment, noting the company is now more mature and can execute a focused GTM strategy. He believes the distance to an optimal capability set is "months of work, not years," and plans to tackle life sciences in the next 12-24 months. The strategy includes product investment, partner ecosystem development, and content aggregation. Q: How is the 365 Talents acquisition influencing enterprise deals and win rates? A: CEO Alessio Artuffo said the integration is ahead of schedule, with pipeline growth exceeding expectations. He cited two significant Q2 winsa world's largest telecom/networking company and a world's largest automotive safety systems supplierthat would not have been possible without 365's capabilities. While not disclosing specific attach rates, he emphasized that 365 is a "second door" into new logos and a retention lever, with many more similar opportunities in the pipeline. Q: Are software sales cycles compressing, and is Docebo seeing this trend? A: CFO Brandon Farma responded that Docebo has not seen elongated sales cycles; in fact, H1 saw decreased sales cycles in several segments due to execution improvements from changes made in July of last year. He clarified that the industry headlines about compression are consistent with Docebo's experience, but the company's improvements are more tied to internal execution than market-wide trends. Q: How does Docebo plan to address concerns about "rogue agents" and ensure guardrails in its Agent Hub? A: CEO Alessio Artuffo emphasized that the AI team has been working on agent technology for a long time and has a strong point of view on reliability, safety, and security. He stated that all builds will include robust safeguards and standards, and Docebo will work closely with customers' security officers to document and validate the safety of its solutions as this is new territory. Q: What is the view on future M&A and capital allocation strategy? A: CEO Alessio Artuffo said the focus is on integrating the 365 and Zive acquisitions, with M&A not a primary focus for net new deals. CFO Brandon Farma added that capital allocation is a daily equation, currently favoring share buybacks given the undervalued stock price. He noted the company has $45 million in cash and $90 million in debt, and while opportunistic M&A is considered, nothing is expected in the next 12 months. Q: How does the healthcare opportunity compare to the government investment, and what milestones should investors expect? A: CEO Alessio Artuffo said the first milestones are staffing a dedicated team across product and GTM, then developing runbooks and vertical-specific problem frameworks. Unlike federal (which requires FedRAMP certification), healthcare success depends on executing people and product vectors to increase win rates. He emphasized Docebo is already winning significant healthcare customers, and the speed of execution will determine share-of-wallet gains. Q: What level of prudence is baked into the guidance, and what changed to raise it? A: CFO Brandon Farma explained the $3.5 million guidance raise includes $1.6 million from Q2 beat and $2.1 million flow-through, with $1.2 million from professional services and $900K from subscriptions. Mid-market assumptions are flat, government expectations were already strong, but enterprise assumptions were increased for H2 based on two quarters of strong win rates and pipeline. He noted the company came into 2026 with conservative flat enterprise growth assumptions, which have now been revised upward. Q: How is the healthcare investment impacting EBITDA guidance, and what is the spend pattern? A: CFO Brandon Farma said EBITDA guidance is unchanged, with healthcare investments being a "relatively small pod" in H2. R&D spend will scale up from Q2 through Q4, while sales and marketing will be down sequentially in Q3 due to event-related spend. The healthcare team will start with a pod of three sellers, following the exact playbook used for the government vertical. For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Investor releaseQuarter not tagged2026-08-07

Docebo Beats Earnings Expectations and Raises Full-Year Outlook

InvestorsHub

Docebo Inc. (NASDAQ:DCBO) reported second-quarter 2026 results that exceeded profit forecasts but came in slightly below revenue expectations. Despite the mixed quarterly performance, the learning management platform provider raised its full-year guidance, helping shares edge modestly higher in premarket trading. Docebo posted adjusted earnings of $0.35 per share, beating analysts’ consensus estimate of $0.30. Subscription revenue totalled $63.8 million, an increase of 12% from $57.1 million in the same quarter last year. However, the figure fell short of Wall Street expectations of $66.88 million. Total revenue rose 13% year over year to $68.7 million, compared with $60.7 million in the second quarter of 2025. President and Chief Executive Officer Alessio Artuffo said, “Q2 was another milestone quarter for Docebo as disciplined execution and long-term investment continued to strengthen our position with enterprise customers around the world.” Adjusted EBITDA increased to $11.2 million, representing 16.4% of total revenue, compared with $9.2 million, or 15.2% of revenue, a year earlier. Net income was $2.3 million, or $0.09 per share, down slightly from $3.1 million, or $0.10 per share, in the prior-year quarter. For the third quarter, Docebo expects subscription revenue of between $64.9 million and $65.1 million, with total revenue forecast at $69.5 million to $69.7 million. The midpoint is broadly in line with analysts’ expectations. The company also expects adjusted EBITDA of between $15.9 million and $16.1 million during the quarter. Looking further ahead, Docebo increased its full-year 2026 outlook. Management now expects subscription revenue of $255.5 million to $257.5 million and total revenue of $274.5 million to $276.5 million. The midpoint of the revised total revenue forecast is slightly above Wall Street’s consensus estimate of $275.2 million. Full-year adjusted EBITDA is projected to range between $54.5 million and $56.5 million. Annual recurring revenue reached $255.1 million as of 30 June 2026, representing growth of 9.5% compared with $233.0 million a year earlier. While investors weighed the softer-than-expected subscription revenue, the stronger earnings performance and improved full-year outlook supported a modest gain in Docebo shares ahead of the opening bell. Docebo stock price

Investor releaseQuarter not tagged2026-08-07

Docebo Inc. (DCBO) Beats Q2 Earnings and Revenue Estimates

Zacks
Docebo Inc. (DCBO) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.29 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +59.09%. A quarter ago, it was expected that this company would post earnings of $0.33 per share when it actually produced earnings of $0.34, delivering a surprise of +3.03%. Over the last four quarters, the company has surpassed consensus EPS estimates four times. Docebo, which belongs to the Zacks Internet - Software industry, posted revenues of $68.65 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 1.16%. This compares to year-ago revenues of $60.73 million. The company has topped consensus revenue estimates four times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Docebo shares have lost about 7.8% since the beginning of the year versus the S&P 500's gain of 12.6%. While Docebo has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Docebo was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #5 (Strong Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It wi…Read full document

Docebo Inc. (DCBO) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.29 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +59.09%. A quarter ago, it was expected that this company would post earnings of $0.33 per share when it actually produced earnings of $0.34, delivering a surprise of +3.03%. Over the last four quarters, the company has surpassed consensus EPS estimates four times. Docebo, which belongs to the Zacks Internet - Software industry, posted revenues of $68.65 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 1.16%. This compares to year-ago revenues of $60.73 million. The company has topped consensus revenue estimates four times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Docebo shares have lost about 7.8% since the beginning of the year versus the S&P 500's gain of 12.6%. While Docebo has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Docebo was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #5 (Strong Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.39 on $69.6 million in revenues for the coming quarter and $1.58 on $275.2 million in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Internet - Software is currently in the top 44% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. Another stock from the same industry, VNET Group (VNET), has yet to report results for the quarter ended June 2026. The results are expected to be released on August 18. This provider of carrier-neutral internet data center services is expected to post quarterly loss of $0.06 per share in its upcoming report, which represents a year-over-year change of -500%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. VNET Group's revenues are expected to be $405.24 million, up 19.3% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Docebo Inc. (DCBO) : Free Stock Analysis Report VNET Group, Inc. - Unsponsored ADR (VNET) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research

Investor releaseQuarter not tagged2026-08-07

Docebo Reports Second Quarter 2026 Results

Business Wire
TORONTO, August 07, 2026--(BUSINESS WIRE)--Docebo Inc. (NASDAQ: DCBO; TSX:DCBO) ("Docebo" or the "Company"), the Enterprise Platform for the AI-era workforce, unifying skills intelligence, learning, and knowledge in one closed loop, announced financial results for the three and six months ended June 30, 2026. All amounts are expressed in US dollars unless otherwise stated. "Q2 was another milestone quarter for Docebo as disciplined execution and long-term investment continued to strengthen our position with enterprise customers around the world," said Alessio Artuffo, President and Chief Executive Officer. "As organizations transition from AI experimentation to enterprise-scale workforce transformation, they are increasingly choosing Docebo as their trusted partner. This sustained traction gives us the confidence to once again raise our full-year financial outlook." Second Quarter 2026 Financial Highlights Subscription revenue of $63.8 million, an increase of 12% from the comparative period in the prior year, including approximately 1 percentage point of positive impact resulting from the weakening of the US dollar relative to foreign currencies. Total revenue of $68.7 million, an increase of 13% from the comparative period in the prior year, including approximately 1 percentage point of positive impact resulting from the weakening of the US dollar relative to foreign currencies. Gross profit of $54.5 million, an increase of 11% from the comparative period in the prior year, represented 79.4% of revenue compared to 80.9% of revenue for the comparative period in the prior year. Net income of $2.3 million, or $0.09 per share, compared to net income of $3.1 million, or $0.10 per share for the comparative period in the prior year. Adjusted Net Income1 of $9.4 million, or Adjusted Earnings per share of $0.37, compared to Adjusted Net Income of $8.9 million, or Adjusted Earnings per share of $0.30, for the comparative period in the prior year. ARR was $255.1 million, an increase of 9.5% from the comparative period in the prior year. ARR was negatively impacted in the quarter by $0.4 million due to the effects of foreign exchange. Our largest OEM customer represented 2.5% of Annual Recurring Revenue as at June 30, 2026, compared to 8.4% as at June 30, 2025. Excluding our largest OEM customer, acquired ARR from acquisitions and after adjusting for the above noted ne…Read full document

TORONTO, August 07, 2026--(BUSINESS WIRE)--Docebo Inc. (NASDAQ: DCBO; TSX:DCBO) ("Docebo" or the "Company"), the Enterprise Platform for the AI-era workforce, unifying skills intelligence, learning, and knowledge in one closed loop, announced financial results for the three and six months ended June 30, 2026. All amounts are expressed in US dollars unless otherwise stated. "Q2 was another milestone quarter for Docebo as disciplined execution and long-term investment continued to strengthen our position with enterprise customers around the world," said Alessio Artuffo, President and Chief Executive Officer. "As organizations transition from AI experimentation to enterprise-scale workforce transformation, they are increasingly choosing Docebo as their trusted partner. This sustained traction gives us the confidence to once again raise our full-year financial outlook." Second Quarter 2026 Financial Highlights Subscription revenue of $63.8 million, an increase of 12% from the comparative period in the prior year, including approximately 1 percentage point of positive impact resulting from the weakening of the US dollar relative to foreign currencies. Total revenue of $68.7 million, an increase of 13% from the comparative period in the prior year, including approximately 1 percentage point of positive impact resulting from the weakening of the US dollar relative to foreign currencies. Gross profit of $54.5 million, an increase of 11% from the comparative period in the prior year, represented 79.4% of revenue compared to 80.9% of revenue for the comparative period in the prior year. Net income of $2.3 million, or $0.09 per share, compared to net income of $3.1 million, or $0.10 per share for the comparative period in the prior year. Adjusted Net Income1 of $9.4 million, or Adjusted Earnings per share of $0.37, compared to Adjusted Net Income of $8.9 million, or Adjusted Earnings per share of $0.30, for the comparative period in the prior year. ARR was $255.1 million, an increase of 9.5% from the comparative period in the prior year. ARR was negatively impacted in the quarter by $0.4 million due to the effects of foreign exchange. Our largest OEM customer represented 2.5% of Annual Recurring Revenue as at June 30, 2026, compared to 8.4% as at June 30, 2025. Excluding our largest OEM customer, acquired ARR from acquisitions and after adjusting for the above noted negative impact due to the effects of foreign exchange, ARR increased by approximately 13.9% from the comparative period in the prior year. Adjusted EBITDA1 of $11.2 million, representing 16.4% of total revenue, compared to $9.2 million, representing 15.2% of total revenue, for the comparative period in the prior year. Cash flows used in operating activities of $3.1 million, compared to $6.2 million generated during the comparative period in the prior year. Free Cash Flow1 of $3.1 million, representing 4.5% of total revenue for the three months ended June 30, 2026, compared to $11.4 million, representing 18.7% of total revenue, for the comparative period in the prior year. As at June 30, 2026, total cash and cash equivalents are expected to be $45.7 million and total borrowings are $88.0 million Second Quarter 2026 Customer Updates Notable new customer wins include a global leader in network infrastructure and telecommunications technology, serving a large ecosystem of internal and external learners, which selected Docebo, 365Talents, and a trusted partner to reinvent its learning and skills ecosystem. Through this platform transformation, the organization will replace multiple legacy systems and unify its internal training, external certifications, eCommerce, and skills-based career development. Building on Docebo's robust integrations, scalable architecture, AI-powered capabilities, and 365Talents' skills intelligence, the organization will enable internal mobility, workforce planning, and revenue-generating certification programs across its global partner ecosystem The world's largest privately owned security services company selected Docebo in a competitive evaluation to replace its existing learning provider in order to unify its internal and external learning ecosystem on a single platform. The company chose Docebo's enterprise-grade platform to support onboarding, compliance, and role-based training across its global workforce of 130,000 people, while launching a multilingual, customer-facing e-commerce training academy that extends learning to external audiences from the same scalable foundation. A global leader in automotive safety, with more than 70,000 employees worldwide, selected Docebo and 365Talents to address a critical enterprise competency management challenge. The organization needed to replace multiple siloed, homegrown systems and Excel-based competency tracking across countries and functions with a unified skills intelligence and learning platform. They chose Docebo for its scalable multi-use-case learning platform capabilities and 365Talents' skills architecture, talent marketplace, and workforce intelligence, enabling upskilling/reskilling pathways, career pathing, gap identification, and knowledge transfer at scale, all integrated within their existing ecosystem. A leading global consulting firm selected Docebo to modernize and future‑proof its learning ecosystem for all internal employees worldwide. The firm selected Docebo for its ability to reliably handle complex, core enterprise LMS requirements at scale, while also delivering an innovative AI strategy and clear vision for the future of learning, including capabilities such as AI Roleplay, MCP, and Companion. As an organization at the forefront of using AI to drive productivity and performance, they will be a strong strategic partner for Docebo to co-innovate and accelerate long-term workforce transformation. In a FedRAMP win, Docebo signed a private sector energy company, which selected our platform in a competitive evaluation to modernize onboarding, compliance, safety, and technical training. The deployment underscores growing demand for Docebo's government-grade learning platform beyond traditional public sector customers, as highly regulated commercial organizations increasingly adopt FedRAMP-grade security and compliance capabilities. Docebo’s Public Sector team continued to build momentum in Q2, highlighted by an expansion with the Commonwealth of Kentucky’s enterprise learning modernization initiative and new wins with the Indiana Public Retirement System and the State of Mississippi. The team also expanded its presence in healthcare through a competitive displacement opportunity in the Philadelphia behavioral health market, reflecting continued demand across Federal, SLED, and regulated industries. Financial Outlook Docebo is providing financial guidance for the three months ending September 30, 2026 as follows: Subscription revenue is expected to be between $64.9 million and $65.1 million Total revenue between $69.5 million and $69.7 million Adjusted EBITDA between $15.9 million to $16.1 million Docebo is providing financial guidance for the fiscal year ending December 31, 2026 as follows: Subscription revenue between $255.5 million and $257.5 million Total revenue between $274.5 million and $276.5 million Adjusted EBITDA between $54.5 million and $56.5 million The information in this section is forward-looking. Please see the sections entitled "Non-IFRS Measures and Reconciliation of Non-IFRS Measures" and "Key Performance Indicators" in this press release for how we define "Adjusted EBITDA" and the section entitled "Forward-Looking Information." A reconciliation of forward-looking "Adjusted EBITDA" to the most directly comparable IFRS measure is not available without unreasonable effort, as certain items cannot be reasonably predicted because of their high variability, complexity and low visibility. Docebo believes that this type of guidance provides useful insight into the anticipated performance of its business. Second Quarter 2026 ResultsSelected Financial Measures Key Performance Indicators and Non-IFRS Measures Conference Call Management will host a conference call on Friday, August 7, 2026 at 8:00 am ET to discuss these second quarter results. To access the conference call, please dial +1-646-960-0169 or +1-888-440-6849 or access the webcast at https://docebo.inc/events-and-presentations/default.aspx. The Company will post Prepared Management Remarks (in .pdf format) regarding its Q2 2026 results, which will be the subject of this call, on the Investor Relations section of Docebo’s website at https://investors.docebo.com. The unaudited condensed consolidated interim financial statements for the six months ended June 30, 2026 and Management’s Discussion & Analysis for the same period have been filed on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Alternatively, these documents along with a presentation in connection with the conference call can be accessed online at https://investors.docebo.com. An archived recording of the conference call will be available until August 14, 2026 and for 90 days on our website. To listen to the recording, please visit the webcast link which can be found on Docebo’s investor relations website at https://docebo.inc/events-and-presentations/default.aspx or call +1-609-800-9909 or +1-800-770-2030 and enter passcode 8722408#. Forward-Looking Information This press release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking information") within the meaning of applicable securities laws. In some cases, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "targets", "expects", "is expected", "an opportunity exists", "budget", "scheduled", "estimates", "outlook", "forecasts", "projection", "prospects", "strategy", "intends", "anticipates", "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might" or, "will", "occur" or "be achieved", and similar words or the negative of these terms and similar terminology. In addition, any statements that refer to expectations, intentions, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management’s expectations, estimates and projections regarding future events or circumstances. This forward-looking information in this press release includes, but is not limited to, statements regarding the Company’s business; the guidance for the three months ended September 30, 2026 in respect of total revenue, Adjusted EBITDA and subscription revenue and fiscal year ended December 31, 2026 in respect of total revenue, Adjusted EBITDA and subscription revenue discussed under "Financial Outlook" in this press release; the impact of AI on our business; future financial position and business strategy; Docebo’s position in the learning management industry; our growth rates and growth strategies; addressable markets for our solutions and; the achievement of advances in and expansion of our platform. This forward-looking information is based on our opinions, estimates and assumptions in light of our experience and perception of historical trends, current conditions and expected future developments, as well as other factors that we currently believe are appropriate and reasonable in the circumstances. Despite a careful process to prepare and review the forward-looking information, there can be no assurance that the underlying opinions, estimates and assumptions will prove to be correct. Certain assumptions include: our ability to build our market share and enter new markets and industry verticals; our ability to attract and retain key personnel; our ability to maintain and expand geographic scope; our ability to execute on our expansion plans, including, but not limited to, our ability to expand upon AI components of our platform; our ability to continue investing in infrastructure to support our growth; our ability to obtain and maintain existing financing on acceptable terms; our ability to execute on profitability initiatives; our ability to maintain the authorization required for use of our platform across the public sector; currency exchange and interest rates; the impact of inflation and global macroeconomic conditions; the impact of competition; our ability to respond to the changes and trends in our industry or the global economy; and the changes in laws, rules, regulations, and global standards are material factors made in preparing forward-looking information and management’s expectations. Forward-looking information is necessarily based on a number of opinions, estimates and assumptions that, while considered by the Company to be appropriate and reasonable as of the date of this press release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to: the Company’s ability to execute its growth strategies; the impact of changing conditions in the global corporate e-learning market; increasing competition in the global corporate e-learning market in which the Company operates; fluctuations in currency exchange rates and volatility in financial markets; changes in the attitudes, financial condition and demand of our target market; the Company’s ability to operate its business and effectively manage its growth under evolving macroeconomic conditions, such as high inflation and recessionary environments; developments and changes in applicable laws and regulations; fluctuations in the length and complexity of the sales cycle for our platform, especially for sales to larger enterprises; issues in the use of AI in our platform and potential resulting reputational harm or liability; and such other factors discussed in greater detail under the "Risk Factors" section of our Annual Information Form dated February 26, 2026 ("AIF"), which is available under our profile on SEDAR+ at www.sedarplus.ca. Our guidance for the three months ending September 30, 2026 in respect of total revenue, Adjusted EBITDA and subscription revenue and for the fiscal year ending December 31, 2026 in respect of total revenue, Adjusted EBITDA and subscription revenue, is in each case subject to certain assumptions and associated risks as stated above under this "Forward-Looking Information," section and in particular the following: foreign exchange rates remain consistent with those in effect as at June 30, 2026; macro-economic conditions will be generally consistent with those experienced in the first half of 2026; 2026 revenue from our largest original equipment manufacturer customer will be approximately 3%-4% of 2026 total revenue and 2026 revenue from our recent acquisition of 365Talents will be approximately US$9,000,000; we will not enter into any new contracts (excluding renewals) in 2026 that provide for more than US$1,000,000 of ARR; we will maintain our customer retention levels, and specifically, our customers will renew contractual commitments on a periodic basis as those commitments come up for renewal, at rates not materially inconsistent with our historical experience; and with respect to Adjusted EBITDA, we will contain expense levels while expanding our business. If any of these risks or uncertainties materialize, or if the opinions, estimates or assumptions underlying the forward-looking information prove incorrect, actual results or future events might vary materially from those anticipated in the forward-looking information. The opinions, estimates or assumptions referred to above and described in greater detail in the "Summary of Factors Affecting our Performance" section of our MD&A for the six months ended June 30, 2026 and in the "Risk Factors" section of our AIF, should be considered carefully by prospective investors. Although we have attempted to identify important risk factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other risk factors not presently known to us or that we presently believe are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking information. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. No forward-looking statement is a guarantee of future results. Accordingly, you should not place undue reliance on forward-looking information, which speaks only as of the date made. The forward-looking information contained in this press release represents our expectations as of the date specified herein, and are subject to change after such date. However, we disclaim any intention or obligation or undertaking to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required under applicable securities laws. All of the forward-looking information contained in this press release is expressly qualified by the foregoing cautionary statements. Additional information relating to Docebo, including our AIF, can be found on SEDAR+ at www.sedarplus.ca. About Docebo Docebo (NASDAQ: DCBO; TSX: DCBO) is the enterprise platform for the AI-era workforce, unifying skills intelligence, learning, and knowledge in one closed loop. Docebo gives organizations the tools to close skills gaps, develop talent, and perform at their best in an AI-driven world. Learn why businesses around the world love Docebo by visiting our customer stories page. Results of Operations The following table outlines our unaudited condensed consolidated interim statements of income and comprehensive income for the following periods: Key Statement of Financial Position Information Non-IFRS Measures and Reconciliation of Non-IFRS Measures This press release makes reference to certain non-IFRS measures including key performance indicators used by management and typically used by our competitors in the SaaS industry. These measures are not recognized measures under IFRS and do not have a standardized meaning prescribed by IFRS and are therefore not necessarily comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of our results of operations from management’s perspective. Accordingly, these measures should not be considered in isolation nor as a substitute for analysis of our financial information reported under IFRS. These non-IFRS measures are used to provide investors with alternative measures of our operating performance and liquidity and thus highlight trends in our business that may not otherwise be apparent when relying solely on IFRS measures. We also believe that securities analysts, investors and other interested parties frequently use non-IFRS measures, including SaaS industry metrics, in the evaluation of companies in the SaaS industry. Management also uses non-IFRS measures to facilitate operating performance comparisons from period to period, the preparation of annual operating budgets and forecasts and to determine components of executive compensation. The non-IFRS measures referred to in this press release include "Annual Recurring Revenue", "Average Contract Value", "Adjusted EBITDA", "Adjusted Net Income", "Adjusted Earnings per Share - Basic and Diluted", "Working Capital" and "Free Cash Flow". Key Performance Indicators We recognize subscription revenues ratably over the term of the subscription period under the provisions of our agreements with customers. The terms of our agreements, combined with high customer retention rates, provides us with a significant degree of visibility into our near-term revenues. Management uses a number of metrics, including the ones identified below, to measure the Company’s performance and customer trends, which are used to prepare financial plans and shape future strategy. Our key performance indicators may be calculated in a manner different than similar key performance indicators used by other companies. Annual Recurring Revenue: We define Annual Recurring Revenue as the annualized equivalent value of the subscription revenue of all existing contracts (including Original Equipment Manufacturer contracts) as at the date being measured, excluding non-recurring revenues from implementation, support and maintenance fees. Our customers generally enter into annual or multi-year contracts which are non-cancellable or cancellable with penalty. Accordingly, our calculation of Annual Recurring Revenue assumes that customers will renew the contractual commitments on a periodic basis as those commitments come up for renewal. Subscription agreements may be subject to price increases upon renewal reflecting both inflationary increases and the additional value provided by our solutions. In addition to the expected increase in subscription revenue from price increases over time, existing customers may subscribe for additional features, learners or services during the term. We believe that this measure provides a fair real-time measure of performance in a subscription-based environment. Annual Recurring Revenue provides us with visibility for consistent and predictable growth to our cash flows. Our strong total revenue growth coupled with increasing Annual Recurring Revenue indicates the continued strength in the expansion of our business and will continue to be our focus on a go-forward basis. Average Contract Value: Average Contract Value is calculated as total Annual Recurring Revenue divided by the number of active customers. Annual Recurring Revenue and Average Contract Value as at June 30, 2026 and 2025 were as follows: Adjusted EBITDA Adjusted EBITDA is defined as net income excluding net finance income, depreciation and amortization, income taxes, share-based compensation and related payroll taxes, other income, foreign exchange gains and losses, acquisition related compensation, transaction related expenses and restructuring costs, if any. The IFRS measure most directly comparable to Adjusted EBITDA presented in our financial statements is net income. The following table reconciles Adjusted EBITDA to net income for the periods indicated: Adjusted Net Income and Adjusted Earnings per Share - Basic and Diluted Adjusted Net Income is defined as net income excluding amortization of intangible assets, share-based compensation and related payroll taxes, acquisition related compensation, transaction related expenses, restructuring costs, foreign exchange gains and losses, and deferred income taxes. Adjusted Earnings per share - basic and diluted is defined as Adjusted Net Income divided by the weighted average number of common shares (basic and diluted). The IFRS measure most directly comparable to Adjusted Net Income presented in our financial statements is net income. The following table reconciles net income to Adjusted Net Income for the periods indicated: Working Capital Working Capital as at June 30, 2026 and 2025 was $(30.2) million and $(5.1) million, respectively. Working Capital is defined as current assets, excluding the current portion of the net investment in finance lease and contract costs, minus current liabilities, excluding borrowings, if any, and the current portion of contingent consideration and lease obligations. The decrease in working capital from June 30, 2026 to June 30, 2025 was driven by the use of cash and cash equivalents to purchase shares under the NCIB and SIB. Working Capital is not a recognized measure under IFRS. The following table represents the Company’s working capital position as at June 30, 2026 and 2025: Free Cash Flow Free Cash Flow is defined as cash flows from operating activities less cash used for purchases of property and equipment and capitalized internal-use software costs, plus non-recurring expenditures such as the payment of acquisition-related compensation, the payment of transaction-related costs, and the payment of restructuring costs. Free Cash Flow is not a recognized measure under IFRS. The IFRS measure most directly comparable to Free Cash Flow presented in our financial statements is cash flow from operating activities. The following table reconciles our cash flows from operating activities to Free Cash Flow for the periods indicated: View source version on businesswire.com: https://www.businesswire.com/news/home/20260807099925/en/ Contacts For further information, please contact: Mike McCarthyVice President - Investor Relations(214) [email protected]

Investor releaseQuarter not tagged2026-08-07

Docebo Q2 Earnings Call Highlights

MarketBeat
Interested in Docebo Inc.? Here are five stocks we like better. Growth re-accelerated for a second consecutive quarter, prompting Docebo to raise its full-year revenue outlook by $3.5 million, primarily due to stronger enterprise performance, pipeline and win rates. Docebo plans to launch its Agent Hub and Enterprise Knowledge products in early fall, supported by forward-deployed engineers who will build customized AI-agent workflows, initially targeting healthcare, financial services and quick-service restaurants. The company is expanding its healthcare focus and integrating 365Talents and Zive to strengthen enterprise and skills-based learning offerings, while prioritizing share repurchases and organic growth over acquisitions. 3 Stocks With High ROE and Market-Beating Growth Potential Docebo (NASDAQ:DCBO) executives said the company’s annual recurring revenue growth re-accelerated for a second consecutive quarter in the second quarter of 2026, supported by enterprise execution, partner activity, international performance and expansion business. Management also discussed planned investments in artificial intelligence, healthcare specialization and product integration following its acquisitions of 365Talents and Zive. Chief Executive Officer Alessio Artuffo said Docebo’s growth has been broad-based across net-new customer wins, expansions and international markets. He attributed the momentum to investments in product development and go-to-market execution, including the acquired capabilities of 365Talents and Zive as well as feature releases in Docebo’s core platform. → Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth Artuffo said partners have become an increasingly important component of the company’s enterprise sales motion. Roughly 80% of Docebo’s enterprise pipeline involves a partner in some capacity, whether through co-selling, implementation work or both, he said. He cited Deloitte and newer partner NIIT among firms working closely with the company. Docebo plans to generally release its Agent Hub and Enterprise Knowledge offerings in the early fall. The company is beginning to hire foundational forward-deployed engineers, or FDEs, to develop custom agent workflows for specific customer needs before expanding the practice. → 4 Oil and Gas ETF Plays as Prices Stay Sky-High Artuffo said the initial focus will be on customers in sectors…Read full document

Interested in Docebo Inc.? Here are five stocks we like better. Growth re-accelerated for a second consecutive quarter, prompting Docebo to raise its full-year revenue outlook by $3.5 million, primarily due to stronger enterprise performance, pipeline and win rates. Docebo plans to launch its Agent Hub and Enterprise Knowledge products in early fall, supported by forward-deployed engineers who will build customized AI-agent workflows, initially targeting healthcare, financial services and quick-service restaurants. The company is expanding its healthcare focus and integrating 365Talents and Zive to strengthen enterprise and skills-based learning offerings, while prioritizing share repurchases and organic growth over acquisitions. 3 Stocks With High ROE and Market-Beating Growth Potential Docebo (NASDAQ:DCBO) executives said the company’s annual recurring revenue growth re-accelerated for a second consecutive quarter in the second quarter of 2026, supported by enterprise execution, partner activity, international performance and expansion business. Management also discussed planned investments in artificial intelligence, healthcare specialization and product integration following its acquisitions of 365Talents and Zive. Chief Executive Officer Alessio Artuffo said Docebo’s growth has been broad-based across net-new customer wins, expansions and international markets. He attributed the momentum to investments in product development and go-to-market execution, including the acquired capabilities of 365Talents and Zive as well as feature releases in Docebo’s core platform. → Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth Artuffo said partners have become an increasingly important component of the company’s enterprise sales motion. Roughly 80% of Docebo’s enterprise pipeline involves a partner in some capacity, whether through co-selling, implementation work or both, he said. He cited Deloitte and newer partner NIIT among firms working closely with the company. Docebo plans to generally release its Agent Hub and Enterprise Knowledge offerings in the early fall. The company is beginning to hire foundational forward-deployed engineers, or FDEs, to develop custom agent workflows for specific customer needs before expanding the practice. → 4 Oil and Gas ETF Plays as Prices Stay Sky-High Artuffo said the initial focus will be on customers in sectors including quick-service restaurants, healthcare and financial services, where companies face data integration, discoverability and validation challenges. The FDEs are expected to work with some of Docebo’s largest customers to build workflows on top of the company’s technology. The longer-term objective is to abstract successful custom agents into broader product offerings that can be made available to more customers, Artuffo said. Management did not provide specific monetization details, saying it expects to update investors after the fall launch of Agent Hub and Enterprise Knowledge. → Sandisk Just Delivered a Blowout Quarter—Here's Why the Stock Is Falling Chief Financial Officer Brandon Farber said early FDE hiring will be treated more like research-and-development expense because the work will begin before the product release. As the company begins charging for professional services or adding AI usage-based or fixed-price offerings, the costs could shift into cost of revenue and affect gross margin, he said. Artuffo also addressed enterprise concerns about AI-agent safeguards. He said Docebo’s AI team has been developing agent technology for some time and that the company will prioritize reliability, security and guardrails. Docebo plans to work with customers and their security officers on documentation and related protections. Management identified healthcare as a targeted growth vertical, describing it as an approximately $3 billion total addressable market within the roughly $30 billion corporate learning market where Docebo operates. Artuffo said the company already generates roughly $10 million in annual recurring revenue from healthcare customers. Docebo plans to invest in dedicated product, sales and partner capabilities for the sector. Artuffo said the company believes it can improve its competitiveness in healthcare within months rather than requiring years of work, although he described life sciences as a more technically complex future opportunity that may be addressed over the next 12 to 24 months. Farber said the healthcare initiative will begin as a relatively small team in the second half of 2026 and will continue to scale into 2027. The company intends to establish a dedicated engineering pod and product manager, along with a healthcare sales leader and an initial team of three sellers. Farber said the approach follows the company’s earlier government investment playbook. Management said progress should be measured initially through staffing, the creation of sector-specific operating plans and product roadmaps, followed by improvements in win rates and customer satisfaction over subsequent quarters. Unlike the federal market, where FedRAMP authorization is a critical requirement, Artuffo said Docebo is already winning meaningful healthcare business and needs to improve its “right to win” through sector knowledge and product development. Artuffo said the integration of 365Talents is ahead of schedule six months after the acquisition. He said the company has exceeded its pipeline targets for the combined enterprise offering, though he did not disclose attach rates or the share of deals influenced by the skills platform. Management said 365Talents has opened doors to enterprise prospects that Docebo may not have reached with its previous capabilities. Artuffo cited wins involving one of the world’s largest telecom and networking companies and the world’s largest supplier of automotive safety systems, saying Docebo would not have been at the table without 365Talents. The skills capabilities also strengthen Docebo’s position in internal learning use cases involving skills-based organizations, upskilling and reskilling, particularly among enterprise and strategic enterprise buyers, Artuffo said. The company is working to further integrate 365Talents into its products, and management expects its agentic AI initiatives to strengthen the connection between skills data and personalized training. Farber said Docebo raised its full-year revenue outlook by $3.5 million from the prior quarter. Of that increase, $1.6 million reflected second-quarter performance and $2.1 million represented expected contribution in the second half, including $1.2 million from professional services and nearly $900,000 from subscription revenue. He said the primary change in the company’s outlook was stronger enterprise assumptions for the second half. Docebo entered 2026 assuming roughly flat enterprise growth, but two quarters of stronger performance, win rates and pipeline gave management confidence to increase those assumptions. Mid-market assumptions remained largely unchanged, while expected government performance, including a stronger third quarter for FedRAMP opportunities, had already been incorporated in prior guidance. Farber said sales cycles have shortened in several segments during the first half, which he attributed in part to sales-process changes implemented after the company’s new chief revenue officer joined around July 2025. On capital allocation, management said share repurchases are currently the priority because it views the stock as undervalued. Farber noted Docebo had announced a $70 million substantial issuer bid funded by $16 million of debt and $10 million of cash. He said the company remains open to opportunistic acquisitions but is focused primarily on integrating 365Talents and Zive and views organic growth as central to its strategy. Docebo is a cloud-based learning management system (LMS) provider that offers enterprise organizations a comprehensive platform for employee, customer and partner training. The company's software is designed to streamline learning and development with features such as AI-powered content recommendations, automated learning paths and social collaboration tools. Docebo's platform supports multiple languages and integrates with a variety of third-party applications, enabling businesses to deliver training at scale across different departments and regions. Founded in 2005 and headquartered in Toronto, Canada, Docebo has expanded its footprint to serve customers in North America, Europe, the Middle East and the Asia Pacific region. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. The article "Docebo Q2 Earnings Call Highlights" was originally published by MarketBeat. View MarketBeat's top stocks for August 2026.

TranscriptFY2026 Q22026-08-07

FY2026 Q2 earnings call transcript

Earnings source - 89 paragraphs
Operator

Good morning, everyone, and welcome to Docebo's second quarter 2026 earnings call. All participants are currently in a listen-only mode. We will open the line for a question and answer session momentarily. Analysts can ask questions by pressing star one on their telephone keypad. If you would like to withdraw your question, again, press star one. We ask that analysts please limit themselves to two questions and return to the queue for any follow-ups. I'd now like to turn the call over to Docebo's Vice President of Investor Relations, Mike McCarthy. Please go ahead, Mike.

Mike McCarthy

Thank you, Krista. Earlier this morning, Docebo issued its Q2 2026 results. The press release, which included a link to management's prepared remarks and our quarterly investor slide deck, were all posted to our investor relations website. This morning's call will allow participants to ask questions about our results and the written commentary that management provided this morning. Before we begin this morning's Q&A, Docebo would like to remind listeners that certain information discussed may be forward-looking in nature. Such forward-looking information reflects the company's current views with respect to future events. Any such information is subject to risks, uncertainties, and assumptions that could cause actual results to differ materially from those projected in the forward-looking statements. For more information on the risks, uncertainties, and assumptions relating to forward-looking statements, please refer to Docebo's public filings, which are available on SEDAR and EDGAR.

Mike McCarthy

During the call, we will reference certain non-IFRS financial measures. Although we believe these measures provide useful supplemental information about our financial performance, they are not recognized measures and do not have standardized meanings under IFRS. Please see our MD&A for additional information regarding our non-IFRS financial measures, including reconciliations to the nearest IFRS measures. Please note that unless otherwise stated, all references to any financial figures are in US dollars. I'd like to turn the call over to Docebo's CEO, Alessio Artuffo, and our CFO, Brandon Farber. Christine, you can open up the line.

Operator

If you would like to ask a question, please press star one on your telephone keypad to raise your hand and join the queue. Your first question comes from Robert Young with Canaccord Genuity. Please go ahead.

Robert Young

Thanks. Good morning. First place, I'm sure there's lots of questions on this core deployed engineer model, place I'd like to start. How is it going to work alongside the existing professional services motion? What's the impact you anticipate on revenue and margins, both gross and EBITDA? I think you said that you're hiring FDEs, where are you in the process of building out that FDE motion?

Alessio Artuffo

Good morning, Rob. It's Alessio. You are correct. We are starting with hiring a foundational FDE. That is intended so that we can build the playbook before we scale that practice further. The way we think about it is fairly straightforward. We think that on top of our upcoming release, the GA of Agent Hub and Enterprise Knowledge, both planned in the early fall, we are going to build custom agents workflows that aim to solve for vertical use cases. Very specific needs that our top customers to begin with have. Think about solving for specific operational challenges across QSR, healthcare, financial services. We know that these organizations have a data challenge. Everyone has an integration challenge. Everyone has a data discoverability and validity challenge. We are going to have these FDEs help with creating these custom workflows on top of our technology. Now, how does this compound?

Alessio Artuffo

How does this create greater value? Our plan is to abstract these agents at a greater product level and make those agents available more broadly to a broader audience. In terms of monetization, look, we are going live with Agent Hub and Enterprise Knowledge in the fall, and we'll update you after that time.

Robert Young

Okay. That's all very helpful. Where is this going to fall inside of the income statement on the cost side? Is it going to be something bundled in? Is it going to impact your gross margins, or is it something that's going to be part of your sales motion? I'm trying to understand where it'll impact the margin structure.

Brandon Farber

Rob, when we start to hire them, it's going to be before the product is released. At the start, it will be more of an R&D type cost. These are going to work with our top 10, top 20 customers. As we think about scaling, charging professional services, this adding usage to our AI, whether that's through credits or fixed price, that's where it flips to gross margin. It really depends on when do they get released, when do we start monetizing. It's either going to be an R&D or cost.

Robert Young

Okay. Second question, just on the confidence in the second half acceleration of ARR. Maybe we could talk about where that's specifically coming from, what gets you the most excited, then if you could touch on Q3 seasonality for the FedRAMP government opportunity alongside that. That'd be helpful. I'll pass the line. Thanks.

Alessio Artuffo

Yeah. Let me talk a bit about the underlying ARR acceleration. This is the second quarter in a row where we have a re-acceleration, for sure we're super pleased with that. Rob, if you recall, in November of 2025, during a conference call, we referred to 2026 as the year of the enterprise. That view into 2026 had a point of view that the initiatives we were taking on the product, as well as broadly execution, were headed in the direction where we thought that 2026 was going to show the results of the work we were doing. When I unpack that, I think it's a story of three vectors, right? There is overall execution, where we made investments across the board over the past several years. There is a story of product with the acquisition of 365Talents and the acquisition of Zive, both.

Alessio Artuffo

Frankly, a re-acceleration of shipping features in our core product as well, right? It's not only a story of buying technologies. To characterize growth re-acceleration, I always like to kind of separate our partner motion because it is a subcategory of execution, but it truly has become important. The large majority of our enterprise pipeline, roughly 80%, has a partner involved in some fashion, whether it's a co-sale fashion, whether it's an implement fashion, most times it's a hybrid of both. Shout out to partners like Deloitte and new partners like NIIT that are really embedded with our org, we work super well together. That story of acceleration is, I would say it hinges on several factors. It's broad-based, right? It's showing in net new, it's showing in expansion, it's showing in international.

Alessio Artuffo

I like that very much because these multiple growth factors don't rely on just one segment doing all the work. As far as the confidence for the future, it's very high. We're extremely pleased with the growth of our pipeline. We look at our pipeline in terms of deals that are significant in material in size, above $500K, yeah, very excited about the coming quarters. As far as federal pipeline and quarter three, look, we think about government more broadly than just federal. We think about government as a combination of our success in state and local, as well as federal. Quarter three is a heavy federal quarter, but we don't disclose what's going to happen in the next quarter. We are just extremely pleased with the pipeline build-up and execution of our teams.

Robert Young

Thanks for taking all the questions.

Alessio Artuffo

Yeah. Thank you, Rob.

Operator

Your next question comes from the line of Ryan MacDonald with Needham & Company. Please go ahead.

Ryan MacDonald

Thanks for taking my questions. Congrats on a great quarter. Alessio, I wanted to ask about the investments and decided you're going to move into healthcare here. Obviously, interesting large opportunity, highly regulated industry, and I feel like there are some sort of correlations to federal government, and obviously we've had those investments over the last couple of years, and that's still sort of starting to generate a return or hit an inflection point. Can you just talk about sort of the decision to move into healthcare, how you think about the timeline for the return on the investments you're going to make there, and where you see a gap within healthcare organizations that you think Docebo can fill?

Alessio Artuffo

Yes. Awesome. Ryan, your premise in seeing some parallels with the investments that we made broadly into government, I think it's very astute. I agree with you. There are several parallels. First, let me ground us in the context of the healthcare market as we have studied it. We value this, so we see this as roughly a $3 billion TAM over a roughly $30 billion corporate learning market that we already operate in. We already have an important base of healthcare customers, call it roughly $10 million of ARR. We've acquired the $10 million of ARR notwithstanding certain gaps of knowledge and product that we are now much more educated about.

Alessio Artuffo

I would say that similarly to what happened in the past with the state and local education market, we have operated opportunistically, but we have not been extremely focused and strategic in the way we've addressed this market. Now, as we are a much more mature company, as we have matured our GTM engine, we believe that as an horizontal player, every opportunity we have to become more efficient in our GTM engine and more efficient in the way we address customers' needs, and build products for targeted audiences, the better off we're going to be. We're going to be better in our success of adoption. We're going to be better in our win rates. It was a no-brainer to start with healthcare because we believe the distance between where we are today capability-wise, and the optimal scenario is very much in reach.

Alessio Artuffo

We don't have to do years of work to be in an optimal scenario to double our win rates. I think we have months of work as opposed to years of work. Now, healthcare is a broad definition and depending on how you slice and dice the verticals, we already have a view that is a multi-year view after which we would tackle life sciences. Life sciences carries along a bit more complexity in terms of technical requirements, which we are already partially addressing, but we're preparing ourselves over the next 12, 24 months to go even deeper. What else can I tell you? I think this is a great market. We're already winning in it. I mentioned it. It's a motion where we're going to invest in products. We're going to invest in the partner ecosystem.

Alessio Artuffo

We have partners that are really great in the healthcare industry, and we work closely with them. Also, when I mentioned the content network, healthcare involves a story of content, our technology being such that you can now aggregate multiple content partners, and we can augment. That part is going to be important for our healthcare customers. Listen, one further validation point, we know that in healthcare alone, there are organizations that are very sizable. Frankly, in ARR, they are comparable to Docebo or in that range. All they do is healthcare learning. Just that validates that if we approach this deeply and become more specialized, which I think is very much in reach, we have an additional growth vector. Very excited about it.

Ryan MacDonald

Yeah, super helpful context and color there. Then, maybe as a follow-up. As we think about your sort of, let's call it the increasing verticalization of the platform, with specific verticals where you've seen some big opportunities, can you just talk about how you're seeing or viewing the balance of sort of the pipeline of opportunities for growth, sort of within some of your, let's call it your core markets or sort of more horizontal applications versus moving more into vertically specific applications? Is the healthcare expansion being done with sort of a view of more of a, let's call it a shorter runway or a limited opportunity within sort of broader enterprise? Or is this just based off of seeing some really nice early success, see a product market fit for the solution, naturally going after a new opportunity? Thanks.

Alessio Artuffo

Yeah. I think a bit the opposite of that. Again, we've built Docebo up to where it is today as a horizontal player, with the exception of government, which we started specializing in a while, we've always recognized that there is greater benefit in the earlier stages of company as being a generalist. As you grow up as a business, you will realize that the generalist categorization starts to become an impediment to healthy growth. It shows in every function of the company. It shows also in the way we support the customers. I'm a big believer that in order to doing a great job with customers, you need to understand their business deeply and you need to address their needs deeply.

Alessio Artuffo

When you know you have, just for a sheer example, somebody in a sales executive capacity that at 9:00 A.M. in the morning has a conversation with a manufacturer, and at 11:00 A.M. with a security company, and at 2:00 P.M. with a healthcare organization. Having that depth of knowledge of the business problems that each of these carry is incredibly hard to scale. I believe that it's incumbent upon us, as we continue to mature, to taking the most valuable verticals and creating a motion around it. The caveat there is there an opportunity to also verticalize the product and create capabilities that go beyond the lingo and the jargon? If there is, the combination of that product build alongside the knowledge creates an unstoppable force and an absolute differentiation in the market.

Alessio Artuffo

We don't see it as a need to find a new pocket, rather as a desire to win at a higher rate and be seen more as a leader in those verticals.

Ryan MacDonald

Thanks a lot.

Operator

Your next question comes from the line of Erin Kyle with CIBC. Please go ahead.

Erin Kyle

Hi, good morning, and thanks for taking the questions. Alessio, maybe a question for you on the skills side. You've described it as a bit of a second door into new logos and a retention lever. Maybe in Q2, can you speak to how many enterprise deals were influenced by having that skills capability, and do you see it lifting your win rates versus a year ago?

Alessio Artuffo

Sure. Thank you for the question. First let me tell you, we are beyond pleased with the progress that we've made so far in the integration process of 365Talents. It's like all integrations and acquisitions, there are always challenges, and we don't shy away from those, but the results speak for themselves. We are six months in, frankly, and our pipe targets, we've blown that up. We are very pleased with seeing the pipeline growth, including the 365Talents in enterprise combined offering. While I can't tell exactly the percentage of deals and attach rates, I don't know that that's something that we are necessarily disclosing. We've mentioned a couple of wins that are very significant in this quarter. One being one of the world's largest telecom and networking companies and one being the world's largest supplier of automotive safety systems.

Alessio Artuffo

We would not have been at the table with them had we not offered the capabilities of 365Talents. To me, that is more than an initial validation. I think it really validates what we originally thought. When I look at our pipeline, there are many more of these coming up. The next step here is the job isn't done, to be clear. The job is far from being done. What we need to do and what we're doing is progressing at fast speed our product integration, so that the story of one plus one equals three becomes even more tangible, even in the product and not just in theory. We are ahead of schedule in that regard. I'm very pleased with our integration here.

Alessio Artuffo

Additionally, I think the story wraps and comes all together as we launch Agent Hub and we develop further our agentic efforts. Agents that reason around data and take into consideration skills in order to train people on what they want and need is the ultimate connection of all of the points here. Again, I can't tell you how excited I am about 365Talents moving forward. More work to do and on the standalone side, we haven't even scratched the surface of the potential of this as a secondary product. That's what we hope to do in 2027 and beyond.

Erin Kyle

Thanks. That's helpful color. Then maybe just on the sales cycle side, we've seen some industry headlines recently about software sales cycles have begun to compress across most ACV buckets. Just wondering if Docebo's seeing this at all across your enterprise customers.

Brandon Farber

Hey there, we have not seen that as of today. If anything, in H1, we've seen sales cycles decrease in a number of segments. A lot of that is related to execution. If you recall, Mark, our new CRO came in roughly July of last year, came in, did some tweaks and changed some processes that we're seeing fruits of that labor in H1. The commentary that you're referring to of other software companies seeing elongated sales cycles is not something we're seeing today.

Erin Kyle

Sorry, Brandon, just to clarify, we were actually seeing headlines that sales cycles were decreasing, not elongating. Good to see that Docebo's seeing the same.

Brandon Farber

Yes, correct. Yep.

Operator

Your next question comes from the line of George Sutton with Craig-Hallum. Please go ahead.

George Sutton

Thank you. Alessio, you called out NIIT. I'm curious if you could just give us a sense of the go to market with them. Is that one of the reasons why you're seeing the enterprise strength that you're seeing?

Alessio Artuffo

George, for sure. NIIT is a relatively new partner. I called them out in the context of our partner motion being a significant contributor to our ARR re-acceleration. Kudos to the partners and to our partnership teams and broadly our GTM teams for the way we're leveraging this partner motion. It's a lot of work. It's not just over the past few months. I wouldn't regard a single partner as part of this. NIIT is a relatively new partner. We're doing great work with them. They have a great penetration. I would equally regard the partners that we worked with longer, like Deloitte, as a firm that is very aligned with the way we operate and we're very close with. Yeah, that's all I have to say about that.

George Sutton

The topic of the week in AI, or certainly one of them, has been around rogue agents. I'm curious with your Agent Hub, how can you give confidence to customers that you've built proper guardrails in to protect them?

Alessio Artuffo

Yeah. Look, first of all, our agents technology is something that we've been working on for a while. We have a very sophisticated team in our AI team that has been doing this for a long time. I trust their knowledge and expertise and depth in this area. Our CTO and I have a very strong point of view on the value of Docebo operating in the enterprise space sits very much also in its reliability and safety and security. Everything we're going to be building is going to have a strong point of view on safeguards and guard rail standards. Frankly, George, I think it's a distinct territory. We're going to be working closely with our customers and their security officers to progress how we document this and how we give confidence to everyone that what we're building is as bulletproof as it can be.

George Sutton

Perfect. Thank you.

Operator

Your next question comes from the line of Matthew VanVliet with Cantor Fitzgerald. Please go ahead.

Matthew VanVliet

Yeah, good morning. Thanks for taking the question. I guess as you look at expanding the product platform into healthcare and a couple other areas you talked about today, then integrating 365Talents, what is the view from here on future M&A in a broader capital allocation strategy?

Alessio Artuffo

I'll start, I don't know if Brandon wants to then follow on the specifics for capital allocation. I would say, in pure business terms, we have executed two M&As with 365Talents and Zive. Different profile in terms of costs, and frankly, different profile in terms of product category and capabilities and whatnot. That has given us the point of view that we have a lot of work to do to truly benefit from what we have acquired. We're well ahead of integration schedule, but the integration and the work that now we can do on top of these technologies and alongside these teams, it's very significant. As a result, we are just incredibly focused on integrating and extracting value and building for future capabilities. We remain opportunistic. We always look at the market.

Alessio Artuffo

We don't disregard any opportunity, but M&A presently, in terms of net new deals, is not our primary focus. Brandon?

Brandon Farber

Yep. On capital allocation, it's something we think about daily, as different variables change, our priorities change. Right now, we look at stock price, we believe it is undervalued, based on the stock price today, we believe that that capital allocation is buying back shares. That could change in a couple weeks, could change in months, depending on how the share price does. We think about interest rates. We think about opportunistic M&A. It's a daily equation, right now, as Alessio mentioned, M&A is not top priority, when we look at the stock price, buying back shares is.

Matthew VanVliet

Okay. Very helpful. Then you mentioned the success of the partner community helping you grow here. How much can you think about sort of the size and scale of that partner community? Are you trying to just maybe focus on going broader and deeper with the partners you have and developing those relationships, or is there still build-out of new partners into the ecosystem that you see on the roadmap?

Alessio Artuffo

There's a great deal of opportunity because the word partner has, in our mind, different connotations. You have different categories of partners, different specialties, different verticalizations, different market positions. Think about content partners are a very important part of our business. We partner with several great companies in that area, it's plausible that we will increase the portfolio even more in the future. System integrators are the ones that we tend to think immediately more of in enterprise context. There is different degrees of system integrators. Some are regional, some are more global, some are very much specialized around certain verticals and sectors. For example, we work closely with a partner called TiER1, a great firm that has a great deal of expertise in the healthcare sector. It's important to have a broad-based, varied strategy around partners.

Alessio Artuffo

Our job, frankly, is to becoming crisper and crisper and more clear as to how to couple partners in the areas where we want to win and continue to execute our GTM together. There's also partnerships that are more product-attached partnerships. I can think of marketplaces initiatives like AWS, where it's less of a commercial-first motion, but it's the ability to attach onto big commercial engines like the Amazon AWS one to enable customers to buy using credits. We've had a lot of deals and customers that have preferred that buying modality as opposed to a direct buying modality. All these avenues of buying, the way we think about it is how can we reduce the risk and friction of purchasing for the customer.

Matthew VanVliet

Great. Thank you.

Operator

Your next question comes from the line of John Shao with TD Cowen. Please go ahead.

John Shao

Morning, guys. Thanks for taking my question. Maybe one more question on the healthcare vertical. Could you compare the healthcare opportunity today to where government was when you first began investing in FedRAMP? What kind of milestones should investors expect over the next 12-18 months to gauge the success?

Alessio Artuffo

The first milestones are going to be setting up the team for success. We are going to be staffing an organization across product and GM to really conquer this new vertical while we continue, by the way, in parallel to winning the vertical. It's a bit like creating a more sophisticated plane while we fly already a plane. Once we have the team in seat, which is we're working on actively, then comes the development of It's org radius. It's the development of runbooks. It's the development of specific vertical product roadmap that allows us to have the confidence that we're executing towards something tangible that then leads to improved win rates, that it leads to customer satisfaction in general. That will occur over the next few quarters.

Alessio Artuffo

I guess differently from federal, okay, in this category, I want to emphasize is that, we're already winning significant customers in healthcare right now. Some of these requirements at times have become more stringent and at times are a little looser. It's not that federal is either you have FedRAMP or you don't have FedRAMP. With healthcare, it's our ability to increase our right to win is going to be dependent upon how fast we execute on the people and product vectors. That's as simple as that. The faster we do all of the above, the faster we're going to increase our share of wallet in that industry.

John Shao

Got it. On FAE, I know it's still relatively early, but could you maybe talk about the revenue opportunity? Is it recurring or one time, and maybe the margin profile?

Alessio Artuffo

I'm hesitant to share details that have not been fully ironed out yet. I describe the FDE opportunity on a principle basis because we believe in this AI era, customers are more and more in need of working with true builders. That's what we're prepared to do. We want to really enter in organizations and not just onboard them and let them do the work. We want to do the work with them and for them towards their own personalized outcomes. How does this translate in a recurring model and the marginality of it? It's something that, of course, we're thinking about deeply, and we believe we have good constructs.

Alessio Artuffo

It's perhaps a bit premature to share in this call, and I feel more comfortable that we're going to have a more polished point of view as we talk in November post our Agent Hub release, which is going to be in the fall.

John Shao

That's great. Thank you.

Alessio Artuffo

Thank you.

Operator

As a reminder, if you would like to ask a question, please press star one on your telephone keypad to raise your hand and join the queue. Your next question comes from the line of Ken Wong with Oppenheimer. Please go ahead.

Ken Wong

Fantastic. Thanks for taking my question. Brandon, I wanted to circle up on the guidance a little bit. You guys have a second straight quarter of accelerating underlying ARR. Just want to get a sense for what level of prudence is baked into the guidance. Have you guys changed your philosophy in terms of handicapping some of the big deal pipeline? Any color there would be helpful.

Brandon Farber

Yeah, maybe let's just take a step back and look at the actual revenue increase. We raised our guidance by $3.5 million relative to last quarter. Transparently, $1.6 million of that was from our Q2 meet, $2.1 million of that is the flow through to H2. Even within that $2.1 million, you have $1.2 million of that being professional services and closer to $900,000 of sub. What's really driving that increase? What assumptions are we changing? When we go through our different segments, mid-market, our assumptions are pretty much flat. We've seen consistent performance. The team is still performing great. There's no changes. Governments, we already had strong expectations built into our guidance, so we knew we were going to execute in Q2. We had a record flat quarter in Q2. Q3, we do expect a solid FedRAMP quarter, and that was always baked into our guidance.

Brandon Farber

What changed? It's really Enterprise. We came into 2026, I talked about it in February, where we assumed roughly flat Enterprise growth, which was conservative. We saw two quarters of great performance, strong win rates, good pipeline, that's given us the confidence to increase our Enterprise assumptions in H2. That's really what's driving the incremental revenue guide.

Ken Wong

Okay. Fantastic. The other half of the guidance, you guys kept EBITDA unchanged. I think you called out healthcare as an investment that you guys are making in the back half. How should we think about the run rate of that investment, is this just a small start that ramps up? Is this something that we should expect to carry into 2027?

Brandon Farber

It's going to be a relatively small pod for H2. The expenses will certainly continue to grow into 2027. How we're thinking about it is that H2 is more heavy on R&D investments. When I think about our spend patterns, like sales and marketing, we know it's going to be down sequentially in Q3. A lot of that is event-related spend that happens in Q2 and Q1. R&D will scale up throughout the year. From Q2, Q3 to Q4, we're going to see R&D scale up, and G&A is going to remain relatively flat. The Constitution team, it's going to be its own pod of engineering team with a specific product manager that's specialized in healthcare.

Brandon Farber

We're going to scale up a sales team with a leader that's specific to healthcare and their own sellers of, we're going to start off small with a team of three, which is exactly what we did in government. We're really following the exact playbook of spend that we did in government.

Ken Wong

All right. Fantastic. Thank you for the color.

Operator

Your next question comes from the line of Gavin Fairweather with ATB Cormark. Please go ahead.

Gavin Fairweather

Oh, hey, good morning and thanks for taking my questions. Maybe just on internal use cases, I'm curious to what extent 365Talents in your AI releases are helping carve out a bit more differentiation in a competitive space, and if you've seen any movement in your win rates as a result.

Alessio Artuffo

You're correct, Gavin. 365Talents is giving us a stronger posture in internal use cases where the topic of SBO or skills-based organization, upskilling and reskilling are critical topics. Frankly, we had a light response prior to 365Talents in that context. That becomes particularly true in the enterprise and strategic enterprise segments. Your observation, therefore, that 365Talents impacts our ability to win at larger scale internal use cases where our capabilities were lighter in the past is correct. When I think about our agentic capabilities, I believe this becomes even more true in the upcoming months. We're seeing a very positive return from the 365Talents side relative to this.

Gavin Fairweather

That's great, very helpful. Just secondly, on the enterprise motion, it's been about a year, maybe a little bit more than that from the leadership changes. You've now had two very good quarters in a row. When you look at the sales team productivity, would you say that you've now kind of hit your stride, or are you seeing still potential improvement in that motion given sales cycle?

Alessio Artuffo

No. First of all, it's a good opportunity to give kudos to our great management team, led by our CRO and our CMO and our EVP of partnerships. These guys have been working super hard and their teams on the enterprise side and even our mid-market function international, because it's not only a story of one segment, as I said earlier, it's a broad-based success. They've been doing really good. As far as whether, have we reached the max of what we can do? I believe there's a lot of runway ahead of us, that both in terms of the single unit productivity per seller. The ability to increase quotas given the amount of products that we are delivering to sales validated by customers and upcoming products, that's just something that we will likely do.

Alessio Artuffo

Also, adding access to capabilities like Enterprise Knowledge and 365Talents opens up new territories in terms of not only companies, buyers, but also buyer personas that we're going to be able to sell into. We're going to get closer, much closer to the CIO office. We're going to get much closer to the Chief People Office as a result of these product capabilities. I think we're starting to scratch the surface of how this can look like over the next three years, and for that, I'm really excited.

Gavin Fairweather

Thanks. I pass the line.

Operator

Your next question comes from the line of Suthan Sukumar with Stifel. Please go ahead.

Suthan Sukumar

Good morning, guys. For my first question, I wanted to touch on the ARR re-acceleration of H2. Obviously, there's some benefits there with the Dayforce and AWS headwinds tapering off this year, allowing the strong underlying growth to show. What is giving you guys that visibility from a net new ARR as a perspective? How much is that growth is coming from expansion versus net new?

Brandon Farber

Thanks, Suthan. It's a good question. As we know, we are starting to lap some of the quarters that make it easier for us to re-accelerate on the top line. Just as a reminder, AWS turned H2 for lots of $4 million, and we have Dayforce, which we've disclosed, has essentially gone from $19.5 million to $6.5 million in the current quarter. We're lapsing in, let's call it, $19 million of headwinds over the next four quarters. What's giving us that confidence? It's really what I talked about before, where we're seeing strengths across our end markets, whether we're talking about mid-markets, gov. If you think about last Q3, we essentially won FedRAMP, I think it was three to four months prior to this September 30th close. We didn't have much of an opportunity to play in the FedRAMP space.

Brandon Farber

This is really what we consider our first Q3 with significant pipe and the ability to win in FedRAMP. We have the FedRAMP opportunity. Enterprise, there's no doubt about it, the year-over-year growth is significant. We're seeing strong performance, good pipeline, and when you just add everything together, it's pretty easy to see how we can re-accelerate on the top line.

Suthan Sukumar

Okay. Good. Thank you for that color. For my second question, I want to touch on more from a balance sheet capital allocation perspective. You guys appear to be in investment mode, given the new FDE model, the healthcare vertical ramp. I have to think strategic acquisitions may still be part of the overall strategy. What is the deleveraging path here to get you to a more flexible balance sheet? Can you remind us on what your capital allocation priorities are?

Brandon Farber

Yeah.

Suthan Sukumar

Thank you.

Brandon Farber

If you look at the numbers today, and I'm just going to use some clean round numbers to make it a little bit easier. We have $45 million in cash. We have about $90 million of debt, let's call it $45 million net debt on our annual EBITDA of $65 million. As we know, we've announced an SIB for $70 million funded by $16 million in debt and $10 million in cash, that would take us from $90 million in debt to $150 million. At the same time, it's a bit of a nuanced question because we don't know how many shares will get tendered in the SIB. If we look at today and you think about a rational investor, our current stock price is relatively close. We're slightly above our SIB price.

Brandon Farber

That would suggest we're going to have fairly to frankly no shares tendered in our SIB. That's just the rational assumption to make as of today. But, always never say never, we need to think about the maximum potential. We do think at the moment, as Alessio mentioned, we are looking at opportunities and active in looking. While Docebo made two acquisitions in H1, we don't believe that's the norm. We are very much an organic growth shop. That's in our DNA, and that will always be part of our DNA. Will we continue to look at other opportunities such as 365Talents that are easier bolt-ons that improve our sales and marketing efficiency because it's an easy add-on? We will look at that, but we just don't see any in the next 12 months.

Brandon Farber

If you think about 12 months of runway or a strong free cash flow generation, we do think we have the capacity to look at maybe decreasing debt capacity and paying down debt, or building up cash through free cash flow generation.

Brandon Farber

On your second question, new logo versus expansion. We are typically 65% new logo at 35% expansion, and we've seen that formula relatively similar in Q2. In Q1, it was a little more heavily shifted towards expansion because we had a couple of large expansions, but we're generally in that 65%-35% range.

Suthan Sukumar

Okay. Good. Thanks for taking my questions, guys. I will pass the line.

Operator

That concludes the question and answer session. I would now like to turn the conference back over to Alessio for closing comments.

Alessio Artuffo

Thank you all for being on the call today, and we look forward to our next earnings call in November. Have a good day.

Operator

Ladies and gentlemen, this does conclude today's conference call. Thank you for your participation, and you may now disconnect.

Investor releaseQuarter not tagged2026-07-17

Docebo Inc. Announces Substantial Issuer Bid, Preliminary Unaudited Second Quarter 2026 Financial Results, Initial Q3-2026 and Revised FY2026 Guidance

Business Wire
TORONTO, July 17, 2026--(BUSINESS WIRE)--Docebo Inc. (NASDAQ: DCBO; TSX: DCBO) ("Docebo" or the "Company"), the Enterprise Platform for the AI-era workforce, unifying skills intelligence, learning, and knowledge in one closed loop, announced that its board of directors (the "Board") has approved a substantial issuer bid (the "Offer") under which the Company will offer to repurchase for cancellation up to US$70,000,000 of its outstanding common shares ("Common Shares") at a price of US$20.40 per Common Share. In connection with the Offer, Docebo also announced preliminary (unaudited) financial results for the three months ended June 30, 2026 and financial guidance for Q3-2026 ending September 30, 2026 and the fiscal year ended December 31, 2026. As previously announced, the Company expects to report its full Q2-2026 financial results before the market opens on Friday, August 7, 2026. Substantial Issuer Bid The Offer will not be conditional upon any minimum number of Common Shares being tendered. The Offer will, however, be subject to other conditions and the Company will reserve the right, subject to applicable laws, to withdraw or amend the Offer, if, at any time prior to the expiration of the Offer, certain events occur. If Common Shares with an aggregate purchase price of more than US$70,000,000 are properly tendered and not properly withdrawn, the Company will purchase the Common Shares on a pro rata basis except that "odd lot" tenders (of holders beneficially owning fewer than 100 Common Shares) will not be subject to pro-ration. The Company is making the Offer as it believes that the recent trading price of its Common Shares is not fully reflective of the value of its business and future prospects. In such circumstances, the Company and the Board believe that the Offer is in the best interests of the Company and represents a desirable use of a portion of its existing liquidity. The Company intends to fund the Offer through a combination of approximately US$10,000,000 of cash on hand and an approximate US$60,000,000 draw down on its credit facility. The Company recently increased the size of its credit facility from US$100,000,000 to US$150,000,000. The Company remains focused on making investments to promote long-term growth and profitability, while creating immediate value for shareholders through the Offer. Following the Offer, the Company expects to…Read full document

TORONTO, July 17, 2026--(BUSINESS WIRE)--Docebo Inc. (NASDAQ: DCBO; TSX: DCBO) ("Docebo" or the "Company"), the Enterprise Platform for the AI-era workforce, unifying skills intelligence, learning, and knowledge in one closed loop, announced that its board of directors (the "Board") has approved a substantial issuer bid (the "Offer") under which the Company will offer to repurchase for cancellation up to US$70,000,000 of its outstanding common shares ("Common Shares") at a price of US$20.40 per Common Share. In connection with the Offer, Docebo also announced preliminary (unaudited) financial results for the three months ended June 30, 2026 and financial guidance for Q3-2026 ending September 30, 2026 and the fiscal year ended December 31, 2026. As previously announced, the Company expects to report its full Q2-2026 financial results before the market opens on Friday, August 7, 2026. Substantial Issuer Bid The Offer will not be conditional upon any minimum number of Common Shares being tendered. The Offer will, however, be subject to other conditions and the Company will reserve the right, subject to applicable laws, to withdraw or amend the Offer, if, at any time prior to the expiration of the Offer, certain events occur. If Common Shares with an aggregate purchase price of more than US$70,000,000 are properly tendered and not properly withdrawn, the Company will purchase the Common Shares on a pro rata basis except that "odd lot" tenders (of holders beneficially owning fewer than 100 Common Shares) will not be subject to pro-ration. The Company is making the Offer as it believes that the recent trading price of its Common Shares is not fully reflective of the value of its business and future prospects. In such circumstances, the Company and the Board believe that the Offer is in the best interests of the Company and represents a desirable use of a portion of its existing liquidity. The Company intends to fund the Offer through a combination of approximately US$10,000,000 of cash on hand and an approximate US$60,000,000 draw down on its credit facility. The Company recently increased the size of its credit facility from US$100,000,000 to US$150,000,000. The Company remains focused on making investments to promote long-term growth and profitability, while creating immediate value for shareholders through the Offer. Following the Offer, the Company expects to continue having access to liquidity which, combined with the cash flow that it expects to generate, will allow the Company to continue investing in areas of growth, including through strategic investments such as acquisitions. Intercap Inc. ("Intercap"), which beneficially owns approximately 63.9% of the Company’s issued and outstanding Common Shares has informed the Company that it intends to participate in the Offer in a manner consistent with maintaining at least its current level of ownership on a percent of outstanding Common Shares basis. To the Company’s knowledge, no other directors or officers have indicated an intention to tender Common Shares to the Offer. Such individuals may sell Common Shares on the TSX or Nasdaq while the Offer is outstanding. The Company has engaged Canaccord Genuity Corp. as financial advisor for the Offer and TSX Trust Company to act as the depositary for the Offer. Any questions or requests for information may be directed to TSX Trust Company, as the depositary for the Offer, at 1-866-600-5869 (Toll Free – North America). The Offer will be for up to approximately 13.8% of the total number of issued and outstanding Common Shares on a non-diluted basis. The Offer is denominated in United States dollars and shareholders will receive payment in United States dollars, while Canadian shareholders will receive payment in Canadian dollars, unless, at their option, they elect to receive payment in United States dollars. The Board has approved the Offer. However, none of the Company, Canaccord Genuity Corp. or TSX Trust Company makes any recommendation to any shareholder as to whether to deposit or refrain from depositing Common Shares under the Offer. Shareholders are urged to evaluate carefully all information in the Offer, consult their own financial, legal, investment and tax advisors, and make their own decisions as to whether to deposit Common Shares under the Offer. The formal offer to purchase and issuer bid circular, letter of transmittal and notice of guaranteed delivery (collectively, the "Offer Documents") containing the terms and conditions of the Offer and instructions for tendering Common Shares will be filed with the applicable securities regulators and mailed to shareholders on or about July 21, 2026. The Offer Documents will be available free of charge under the Company’s SEDAR+ profile at www.sedarplus.ca and on EDGAR at www.sec.gov. Shareholders should carefully read the Offer Documents prior to making a decision with respect to the Offer. In particular, the Offer Documents describe certain tax consequences to shareholders of selling Common Shares under the Offer, including that shareholders who sell Common Shares under the Offer are generally expected to be deemed to receive a dividend equal to the excess of the purchase price over the paid-up capital of a Common Share for purposes of the Income Tax Act (Canada), which paid-up capital the Company estimates will be approximately C$10.97 per Common Share. The Company has temporarily suspended purchases of Common Shares pursuant to the Company’s normal course issuer bid, which commenced on May 20, 2026 and expires no later than May 19, 2027 in accordance with applicable securities legislation. The Offer referred to in this press release has not yet commenced. This press release is for informational purposes only and does not constitute an offer to buy or the solicitation of an offer to sell Common Shares. The solicitation and the offer to buy Common Shares will only be made pursuant to the Offer Documents to be filed with the applicable securities regulators in Canada and the United States. Preliminary (Unaudited) Second Quarter 2026 Financial Results In connection with the Offer, Docebo also announced preliminary (unaudited) financial results for the three months ended June 30, 2026. Subscription revenue is expected to be between US$63.5 and US$63.7 million for the second quarter of 2026, an increase of 11.2% to 11.6% compared to US$57.1 million for the second quarter of 2025 Total revenue is expected to be between US$68.3 and US$68.5 million for the second quarter of 2026, an increase of 12.5% to 12.9% compared to US$60.7 million for the second quarter of 2025 Adjusted EBITDA1 is expected to be between US$10.9 and US$11.1 million for the second quarter of 2026, an increase of 18.5% to 20.7% compared to US$9.2 million for the second quarter of 2025 Annual Recurring Revenue1 is expected to be US$255.1 million as at June 30, 2026, an increase of 9.5% compared to US$233.1 million as at June 30, 2025. ARR was negatively impacted in the quarter by US$0.4 million due to the effects of foreign exchange Our largest OEM customer is expected to represent 2.5% of ARR as of June 30, 2026, compared to 8.4% as of June 30, 2025. Excluding our largest OEM customer, acquired ARR from acquisitions and after adjusting for the above noted negative impact due to the effects of foreign exchange, ARR as of June 30, 2026 increased by approximately 13.9% from the same date in the prior year. At June 30, 2026, total cash and cash equivalents are expected to be US$45.7 million and total borrowings were US$88.0 million. 1 Please refer to the "Non-IFRS Measures and Key Performance Indicators" section of this press release. These estimates are preliminary and are inherently uncertain due to a number of factors. They remain subject to Docebo management and Audit Committee reviews and the completion of regular financial closing and review procedures for the three months ended June 30, 2026. Additional adjustments to the preliminary estimates presented above may be identified, and final results for the relevant fiscal periods may differ materially from these preliminary estimates and will not be finalized until after the Company completes its normal quarter-end accounting procedures, including execution of internal controls over financial reporting, and its external auditors, KPMG LLP, completes their review of the consolidated financial statements for the quarter ended June 30, 2026. These preliminary estimates are intended to provide information about management’s current expectations regarding certain aspects of Docebo’s financial performance. Reliance on the information presented herein may not be appropriate for other purposes. Financial Outlook Docebo is providing new and updated financial guidance as follows: Initial Guidance for Q3-2026 Subscription revenue is expected to be between US$64.9 million and US$65.1 million Total revenue is expected to be between US$69.5 and US$69.7 million Adjusted EBITDA is expected to be between US$15.9 and US$16.1 million Revised Guidance for Fiscal Year ended December 31, 2026 Subscription revenue is expected to be between US$255.5 million and US$257.5 million Total revenue is expected to be between US$274.5 and US$276.5 million Adjusted EBITDA is expected to be between US$54.5 and US$56.5 million The information in this section is forward-looking. Please see the sections titled "Non-IFRS Measures and Key Performance Indicators" in this press release for how we define "Adjusted EBITDA" and the section titled "Forward-Looking Information." Docebo believes that this type of guidance provides useful insight into the anticipated performance of its business. Forward-Looking Information This news release may contain "forward-looking information" and "forward-looking statements" (collectively, "forward-looking information") within the meaning of applicable securities laws. In some cases, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "targets", "expects", "is expected", "an opportunity exists", "budget", "scheduled", "estimates", "outlook", "forecasts", "projection", "guidance", "prospects", "strategy", "intends", "anticipates", "believes", "assumes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might" or, "will", "occur" or "be achieved", and similar words or the negative of these terms and similar terminology. In addition, any statements that refer to expectations, intentions, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management’s expectations, estimates and projections regarding future events or circumstances. This forward-looking information in this press release includes, but is not limited to, statements regarding the Company’s business; statements regarding Docebo’s preliminary estimates for revenue, Adjusted EBITDA, and annual recurring revenue for the three months ended June 30, 2026; the guidance for the three months ended September 30, 2026 and fiscal year ended December 31, 2026 in respect of subscription revenue, total revenue and Adjusted EBITDA and discussed under "Financial Outlook" in this press release; the Company’s intention to commence the Offer, the size, timing, tax consequences, terms and conditions of the Offer; participation in the Offer by Intercap and directors and officers of the Company; potential sales of Common Shares outside the Offer by directors or officers of the Company; the Company’s cash strategy and future cash levels; the Company’s ability to draw on its credit facility on terms and within the timeline currently anticipated; the Company’s acquisition strategy and investments to promote long-term growth and profitability of the Company’s business; and the Company’s positioning for future success. This forward-looking information is based on our opinions, estimates and assumptions in light of our experience and perception of historical trends, current conditions and expected future developments, as well as other factors that we currently believe are appropriate and reasonable in the circumstances. Despite a careful process to prepare and review the forward-looking information, there can be no assurance that the underlying opinions, estimates and assumptions will prove to be correct. Certain assumptions include those relating to: our ability to build our market share and enter new markets and industry verticals; our ability to attract and retain key personnel; our ability to maintain and expand geographic scope; our lender’s agreement to increase the size of our credit facility on the terms and timing proposed; our ability to execute on our expansion plans; our ability to continue investing in infrastructure to support our growth; our ability to obtain and maintain existing financing on acceptable terms; our ability to execute on profitability initiatives; our ability to maintain the authorization required for use of our platform across the public sector; currency exchange and interest rates; the impact of inflation and global macroeconomic conditions; the impact of competition; our ability to respond to the changes and trends in our industry or the global economy; and the changes in laws, rules, regulations, and global standards are material factors made in preparing forward-looking information and management’s expectations. Forward-looking information is also subject to a number of risks that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to, risks that the Company will perform as expected and those factors discussed in greater detail under the "Risk Factors" section in our Annual Information Form dated February 26, 2026 (the "AIF"), available free of charge under the Company’s profile on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov, and should be considered carefully by prospective Investors. Our guidance for the third quarter of 2026 and fiscal year ended December 31, 2026 in respect of subscription revenue, total revenue and Adjusted EBITDA is in each case subject to certain assumptions and associated risks as stated above under this "Forward-Looking Information" section and in particular that: foreign exchange rates remain consistent with those in effect as at June 30, 2026; macro-economic conditions will be generally consistent with those experienced in the first half of 2026; 2026 revenue from our largest original equipment manufacturer customer will be approximately 3-4% of 2026 total revenue and 2026 revenue from our recent acquisition of 365Talents will be approximately US$9,000,000; we will not enter into any new contracts (excluding renewals) in 2026 that provide for more than US$1,000,000 of ARR; we will maintain our customer retention levels, and specifically, that our customers will renew contractual commitments on a periodic basis as those commitments come up for renewal, at rates not materially inconsistent with our historical experience; and with respect to Adjusted EBITDA, we will contain expense levels while expanding our business. If any of these risks or uncertainties materialize, or if the opinions, estimates or assumptions underlying the forward-looking information prove incorrect, actual results or future events might vary materially from those anticipated in the forward-looking information. Although we have attempted to identify important risk factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other risk factors not presently known to us or that we presently believe are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking information. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. No forward-looking statement is a guarantee of future results. Accordingly, you should not place undue reliance on forward-looking information, which speaks only as of the date made. The forward-looking information contained in this press release represents our expectations as of the date specified herein and are subject to change after such date. However, we disclaim any intention or obligation or undertaking to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required under applicable securities laws. All of the forward-looking information contained in this press release is expressly qualified by the foregoing cautionary statements. Additional information relating to Docebo, including our AIF, can be found on SEDAR+ at www.sedarplus.ca. About Docebo Docebo (NASDAQ: DCBO; TSX: DCBO) is the enterprise platform for the AI-era workforce, unifying skills intelligence, learning, and knowledge in one closed loop. Docebo gives organizations the tools to close skills gaps, develop talent, and perform at their best in an AI-driven world. Learn why businesses around the world love Docebo by visiting our customer stories page. Non-IFRS Measures and Key Performance Indicators This press release makes reference to certain non-IFRS measures including key performance indicators used by management and typically used by our competitors in the software-as-a-service ("SaaS") industry. These measures are not recognized measures under IFRS and do not have a standardized meaning prescribed by IFRS and are therefore not necessarily comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of our results of operations from management’s perspective. Accordingly, these measures should not be considered in isolation nor as a substitute for analysis of our financial information reported under IFRS. These non-IFRS measures are used to provide investors with alternative measures of our operating performance and liquidity and thus highlight trends in our business that may not otherwise be apparent when relying solely on IFRS measures. We also believe that securities analysts, investors and other interested parties frequently use non-IFRS measures, including SaaS industry metrics, in the evaluation of companies in the SaaS industry. Management also uses non-IFRS measures to facilitate operating performance comparisons from period to period, the preparation of annual operating budgets and forecasts and to determine components of executive compensation. The non-IFRS measures referred to in this press release include "Adjusted EBITDA", and "Annual Recurring Revenue". Many of the Adjusted EBITDA figures in this press release are forward-looking in nature. The differences between the Adjusted EBITDA figures in this press release that are forward-looking and the equivalent historical non-IFRS financial measures are generally a result of our expected increase in 2026 revenues, as described above. For a reconciliation of the third quarter and fiscal year 2026 Adjusted EBITDA figures to their nearest IFRS measure (being net income) please see the section titled "Key Performance Indicators" in the Company’s Management’s Discussion and Analysis for the quarter ended September 30, 2025 and year ended December 31, 2025, which sections are incorporated by reference into this press release and is available under our profile on SEDAR+ at www.sedarplus.ca. We recognize subscription revenues ratably over the term of the subscription period under the provisions of our agreements with customers. The terms of our agreements, combined with high customer retention rates, provides us with a significant degree of visibility into our near-term revenues. Management uses a number of metrics, including the ones identified below, to measure the Company’s performance and customer trends, which are used to prepare financial plans and shape future strategy. Our key performance indicators may be calculated in a manner different than similar key performance indicators used by other companies. · Annual Recurring Revenue: We define Annual Recurring Revenue as the annualized equivalent value of the subscription revenue of all existing contracts (including Original Equipment Manufacturer contracts) as at the date being measured, excluding non-recurring revenues from implementation, support and maintenance fees. Our customers generally enter into annual or multi-year contracts which are non-cancellable or cancellable with penalty. Accordingly, our calculation of Annual Recurring Revenue assumes that customers will renew the contractual commitments on a periodic basis as those commitments come up for renewal. Subscription agreements may be subject to price increases upon renewal reflecting both inflationary increases and the additional value provided by our solutions. In addition to the expected increase in subscription revenue from price increases over time, existing customers may subscribe for additional features, learners or services during the term. We believe that this measure provides a fair real-time measure of performance in a subscription-based environment. Annual Recurring Revenue provides us with visibility for consistent and predictable growth to our cash flows. · Adjusted EBITDA: We define Adjusted EBITDA as net income excluding net finance income, depreciation and amortization, income taxes, share-based compensation and related payroll taxes, other income, foreign exchange gains and losses, acquisition related compensation, transaction related expenses and restructuring costs, if any. The IFRS measure most directly comparable to Adjusted EBITDA presented in our financial statements is net income. View source version on businesswire.com: https://www.businesswire.com/news/home/20260717388795/en/ Contacts For further information, please contact: Mike McCarthyVice President – Investor Relations(214) [email protected]

Investor releaseQuarter not tagged2026-07-17

Docebo Announces up to $70 Million Substantial Issuer Bid, Reports Preliminary Q2 Results

MT Newswires

Docebo (DCBO.TO) approved a substantial issuer bid to buy back up to $70 million shares at $20.40 ea

Investor releaseQuarter not tagged2026-07-06

Docebo to Host Second Quarter Fiscal 2026 Conference Call

Business Wire

TORONTO, July 06, 2026--(BUSINESS WIRE)--Docebo Inc. (Nasdaq:DCBO; TSX:DCBO) ("Docebo" or the "Company"), the Enterprise Platform for the AI-era workforce, unifying skills intelligence, learning, and knowledge in one closed loop, announced today that it will hold a conference call to discuss its second quarter fiscal year 2026 results on Friday, August 7, 2026 at 8:00 a.m. (ET). Alessio Artuffo, President and Chief Executive Officer, and Brandon Farber, Chief Financial Officer will host a live question and answer session to discuss these results. Docebo will report its financial results on the morning of Friday, August 7, 2026 prior to the call. In addition to the press release, the Company will simultaneously post a copy of management’s prepared remarks (in .pdf format) on the Company's website at www.docebo.com. Second Quarter Fiscal Year 2026 Conference Call Details: About DoceboDocebo (NASDAQ: DCBO; TSX: DCBO) is the enterprise platform for the AI-era workforce, unifying skills intelligence, learning, and knowledge in one closed loop. Docebo gives organizations the tools to close skills gaps, develop talent, and perform at their best in an AI-driven world. Learn why businesses around the world love Docebo by visiting our customer stories page. View source version on businesswire.com: https://www.businesswire.com/news/home/20260706982326/en/ Contacts For further information, please contact:Mike McCarthyVice President - Investor [email protected] +1.214.830.0641

Investor releaseQuarter not tagged2026-06-09

Docebo Inc. Announces Voting Results from its Annual General Meeting of Shareholders

Business Wire

TORONTO, June 09, 2026--(BUSINESS WIRE)--Docebo Inc. (NASDAQ: DCBO; TSX: DCBO) ("Docebo" or the "Company") announced today the results of voting at its annual general meeting of shareholders held on June 9, 2026 (the "Meeting"). Each of the seven nominees listed in the Company’s management information circular dated April 6, 2026 provided in connection with the Meeting were elected as directors of the Company. Docebo received proxies and virtual votes at the Meeting as set out below: In addition, Docebo reports that an ordinary resolution approving the appointment of KPMG LLP as Docebo’s auditors for the 2026 fiscal year was passed by a majority of the votes represented at the Meeting. Details of the voting results on all matters considered at the Meeting are available in the Company’s report of voting results, which is available under Docebo’s profile on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. About Docebo Docebo is redefining the way enterprises leverage technology to create and manage content, deliver training, and measure the business impact of their learning programs. With Docebo’s end-to-end learning platform, organizations worldwide are equipped to deliver scaled, personalized learning across all their audiences and use cases, driving growth and powering their business. View source version on businesswire.com: https://www.businesswire.com/news/home/20260609134960/en/ Contacts Mike McCarthyVice President – Investor Relations(214) [email protected]

As of 2026-09-12 • Updated weeklySource: Earnings sourceIngestion runbook